In stage II/III node positive patients with driver mutations positive NSCLC who are not surgical candidates and are unlikely to tolerate concurrent chemotherapy and radiation, would you consider radiation alone, TKI alone, or would you ever consider TKI + RT?   

What would be the treatment duration if using oral TKI?

Answer from: Medical Oncologist at Community Practice
Medical Oncologist at Emory University School of Medicine
Very nice approach. I am curious to know about you...
Sign in or Register to read more